Related Experiment Video
Updated: Mar 29, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
A Dose-Response Study on the Relationship Between Red Meat Intake and Metabolic Dysfunction-Associated Steatotic
Davide Guido1, Manuela Siani1, Maria Noemy Pastore1
1Unit of Data Science, National Institute of Gastroenterology "Saverio de Bellis", IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy.
Abstract:
(1) Background: Metabolic dysfunction-associated liver disease (MASLD) has emerged as a leading cause of liver conditions globally. The increasing trend in meat consumption, particularly red meat, has prompted examination of its effects on cardiometabolic health. This study aimed to explore how varying levels of red meat intake relate to MASLD in a population from Southern Italy. (2) Methods: We analyzed data from a cross-sectional study involving 1192 participants (42.7% male), with complete data available from the second NUTRIHEP survey wave (2014-2016). Statistical analysis utilized adjusted dose-response modeling. (3) Results: Subjects with MASLD numbered 587 (49.2%), including 278 males (54.6%) and 309 females (45.2%). Red meat consumption between 75 and 90 g/day revealed an unfavorable influence on MASLD in males. Interestingly, sex seem to play a role in this association, both in harmful (OR > 1) and protective (OR < 1) ways, associated with specific foods such as liver (OR = 0.936, p = 0.087) and red meatballs (OR = 0.584, p = 0.023) in males and roast red meat (OR = 2.152, p = 0.097), red cutlet (OR = 0.540, p = 0.087), and red meat slices (OR = 0.952, p = 0.076) in females. (4) Conclusions: A suspicious dose-response relationship was observed solely in men, limited to intake levels between 75 and 90 g/day. Overall, red meat consumption did not exhibit a consistent dose-response trend with MASLD. Furthermore, preferences for specific types, cuts, and preparations of red meat were differentially associated with metabolic outcomes based on sex.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

